title: Rituximab and glucocorticoids: friends or foes? It is all about timing.
authors.affiliation: a Robert H. Lurie Comprehensive Cancer Center and Feinberg School of Medicine, Northwestern University , Chicago , IL , USA.
authors.forename: Shuo
authors.initials: S
authors.lastname: Ma
authors.affiliation: a Robert H. Lurie Comprehensive Cancer Center and Feinberg School of Medicine, Northwestern University , Chicago , IL , USA.|b Department of Medicine , Jesse Brown VA Medical Center , Chicago , IL , USA.
authors.forename: Leonidas C
authors.initials: LC
authors.lastname: Platanias
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000235:genetics*; D003907:Dexamethasone / Q000494:pharmacology*; D006801:Humans; D008224:Lymphoma, Follicular / Q000378:metabolism*; D000069283:Rituximab / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D000069283:Rituximab; D003907:Dexamethasone